Literature DB >> 28331437

Letters to the Editor.

.   

Abstract

Year:  2017        PMID： 28331437      PMCID： PMC5349630          DOI： 10.1043/1524-5012-17.1.2

Source DB:  PubMed          Journal:  Ochsner J        ISSN： 1524-5012


× No keyword cloud information.
  13 in total

1.  Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk.

Authors:  Edi Kaminska; Isha Patel; Tushar S Dabade; Jongwha Chang; Ayub A Qureshi; Jenna L O'Neill; Rajesh Balkrishnan; Steven R Feldman
Journal:  J Dermatolog Treat       Date:  2011-07-14       Impact factor: 3.359

2.  Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.

Authors:  Przemyslaw J Kotyla; Bogna Sliwinska-Kotyla; Eugene J Kucharz
Journal:  Clin Rheumatol       Date:  2007-06-05       Impact factor: 2.980

3.  Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System.

Authors:  P Deepak; D J Stobaugh; M Sherid; H Sifuentes; E D Ehrenpreis
Journal:  Aliment Pharmacol Ther       Date:  2013-06-26       Impact factor: 8.171

4.  Occurrence of valves in the main trunk of the renal vein.

Authors:  N E Ahlberg; O Bartley; N Chidekel
Journal:  Acta Radiol Diagn (Stockh)       Date:  1968-09

5.  Renal vein valves: incidence and significance.

Authors:  C F Beckmann; H L Abrams
Journal:  Radiology       Date:  1978-05       Impact factor: 11.105

6.  F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.

Authors:  Nghi C Nguyen; Isaac Tran; Christopher N Hueser; Dana Oliver; Hussein R Farghaly; Medhat M Osman
Journal:  Clin Nucl Med       Date:  2009-12       Impact factor: 7.794

7.  Renal vein valves.

Authors:  J A Oleaga; E J Ring; D Freiman; J W Husted
Journal:  AJR Am J Roentgenol       Date:  1978-05       Impact factor: 3.959

8.  False positive 18F-FDG-PET/CT in a patient after talc pleurodesis.

Authors:  Hojjat Ahmadzadehfar; Holger Palmedo; Holger Strunk; Hans-Jürgen Biersack; Elham Habibi; Samer Ezziddin
Journal:  Lung Cancer       Date:  2007-07-10       Impact factor: 5.705

Review 9.  Demyelination and other neurological adverse events after anti-TNF therapy.

Authors:  Evripidis Kaltsonoudis; Paraskevi V Voulgari; Spyridon Konitsiotis; Alexandros A Drosos
Journal:  Autoimmun Rev       Date:  2013-09-12       Impact factor: 9.754

10.  Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Authors:  Evripidis Kaltsonoudis; Anastasia K Zikou; Paraskevi V Voulgari; Spyridon Konitsiotis; Maria I Argyropoulou; Alexandros A Drosos
Journal:  Arthritis Res Ther       Date:  2014-06-17       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.